Key result
Increased NT-proBNP levels significantly correlated with impaired renal function in patients with heart failure, though this relationship decreased in patients over 85 years of age.
Why the study?
To investigate whether increased NT-proBNP levels are associated with impaired cardiac and renal function in elderly and middle-aged patients.
Observational (n=374)
No
NT-proBNP levels in elderly patients with heart failure should be evaluated considering both the patient's age group and renal impairment.
Answers are grounded in this paper and cite their sources.
May warrant age-adjusted NT-proBNP thresholds in elderly HF; leaves open prospective validation of renal interactions.
Objectives: The aim of this study was to investigate the hypothesis that increased NT pro-BNP levels may be associated with impaired cardiac and renal function in elderly and middle-aged patients. Therefore, we have examined possible relationships between NT-PROBNP levels and other tests in every aspect. Methods: The data of NT-proBNP, Urea, Creatinine, GFR, CK-MB, Trop I and CRP tests of 374 patients admitted to our hospital between September 2019 and November 2019 were evaluated retrospectively. In order to determine the effect of renal dysfunction on NT-proBNP test levels, four study groups, one control group, were formed according to age and NT-proBNP test levels. Results: NT-proBNP levels below <125 pg / ml and within the normal reference value range of the control group were 80.7 ± 14.6 pg / ml. The average age. 59.1 ± 13.5. Significant correlations were found between NT-proBNP levels and Age, Urea, GFR, CK-MB and Trop I levels in this group. (respectively, r: 0.45, P <0.001; r: 0.23, P <0.01; r: -0.17, P <: 0.05; r: 0.18, P <0.05 0.36, P <0.001). Significant correlations were found between NT-proBNP levels and Urea, krea, GFR and Trop I levels in the group of patients aged> 81-102 years with NT-proBNP levels> 10000 pg / ml. (respectively, r: 0.25, P <0.05; r: 0.32, P <0.01; r: -0.25, P <: 0.05; r: 0.33, P <0 , 01). Conclusion: This study showed that NT pro-BNP levels in elderly patients with heart failure and renal dysfunction should be evaluated by considering the patient's renal impairment as well as the age group.
No takes yet. Share an insight, caveat, or question.
Ünsal Gündoğdu (2020) conducted an observational in Heart failure and renal dysfunction (n=374). NT-proBNP testing vs. Normal NT-proBNP levels (<125 pg/ml) was evaluated on Correlation between NT-proBNP and GFR in patients aged 81-102 years with NT-proBNP >10000 pg/ml (r=-0.25, p=<0.05). Increased NT-proBNP levels significantly correlated with impaired renal function in patients with heart failure, though this relationship decreased in patients over 85 years of age.
Synapse has enriched 10 related papers. Consider them for comparative context: